Claret Asset Management Corp Bristol Myers Squibb CO Transaction History

Claret Asset Management Corp

$562 Million
Q2 2024

A detailed history of Claret Asset Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Claret Asset Management Corp holds 173,079 shares of BMY stock, worth $9.4 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

173,079

Previous 167,247 3.49%

Holding current value

$9.4 Million

Previous $9.07 Million 20.75%

% of portfolio

1.28%

Previous 1.52%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $234,738 - $309,037	5,832 Added 3.49%	173,079 $7.19 Million
Q1 2024 Apr 29, 2024	BUY	$47.98 - $54.4 $1.02 Million - $1.15 Million	21,183 Added 14.5%	167,247 $9.07 Million
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $573,954 - $684,886	11,839 Added 8.82%	146,064 $7.5 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $76,588 - $85,637	1,323 Added 1.0%	134,225 $7.79 Million
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $599,957 - $666,158	9,417 Added 7.63%	132,902 $8.5 Million
Q1 2023 Apr 18, 2023	BUY	$65.71 - $74.53 $1.86 Million - $2.11 Million	28,258 Added 29.67%	123,485 $8.56 Million
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $26,501 - $31,381	-387 Reduced 0.4%	95,227 $6.85 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $26 - $15,905	207 Added 0.22%	95,614 $6.8 Million
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $125,487 - $138,205	1,728 Added 1.84%	95,407 $7.35 Million
Q1 2022 Apr 04, 2022	BUY	$61.48 - $73.72 $1.24 Million - $1.49 Million	20,175 Added 27.45%	93,679 $6.84 Million
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $1.76 Million - $2.05 Million	32,825 Added 80.69%	73,504 $4.58 Million
Q3 2021 Dec 02, 2021	BUY	$59.17 - $69.31 $483,892 - $566,817	8,178 Added 25.16%	40,679 $2.41 Million
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $735,490 - $800,949	11,880 Added 57.61%	32,501 $2.17 Million
Q4 2020 Feb 02, 2021	SELL	$57.74 - $65.43 $8,314 - $9,421	-144 Reduced 0.69%	20,621 $1.28 Million
Q3 2020 Oct 29, 2020	SELL	$57.43 - $63.64 $3,675 - $4,072	-64 Reduced 0.31%	20,765 $1.25 Million
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $24,394 - $28,520	445 Added 2.18%	20,829 $1.23 Million
Q1 2020 Apr 06, 2020	BUY	$46.4 - $67.43 $417 - $606	9 Added 0.04%	20,384 $1.14 Million
Q4 2019 Jan 07, 2020	BUY	$49.21 - $64.19 $59,740 - $77,926	1,214 Added 6.34%	20,375 $1.31 Million
Q3 2019 Oct 11, 2019	BUY	$42.77 - $50.71 $91,014 - $107,910	2,128 Added 12.49%	19,161 $972,000
Q2 2019 Jul 24, 2019	BUY	$44.62 - $49.34 $18,606 - $20,574	417 Added 2.51%	17,033 $772,000
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $1,560 - $2,023	-32 Reduced 0.19%	16,616 $864,000
Q3 2018 Oct 30, 2018	BUY	$55.19 - $62.25 $35,928 - $40,524	651 Added 4.07%	16,648 $1.03 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $4,295 - $5,353	-85 Reduced 0.53%	15,997 $885,000
Q4 2017 Mar 27, 2018	BUY	$59.94 - $65.35 $963,955 - $1.05 Million	16,082	16,082 $986,000

Others Institutions Holding BMY

# of Institutions

2,449

Shares Held

1.51B

Call Options Held

29.7M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.

Account

Claret Asset Management Corp Bristol Myers Squibb CO Transaction History